The Inflation Reduction Act’s drug price-setting provisions have drawn significant rebuke from experts who argue that many clinical programs will ultimately be killed or never get started as a result of the act’s deleterious effects on innovation. What isn’t getting attention is how the law is reshaping Medicare in big ways.
Yes, Democrats have finally achieved their holy grail of being able to have the government set drug prices, and President Biden will certainly campaign ...